Wegovy® Consultation Program
Starting at $129
Wegovy® is an FDA-approved prescription medication for chronic weight management in adults who meet specific BMI criteria. It contains semaglutide, a GLP-1 receptor agonist that helps regulate appetite and food intake through the brain–gut connection.
Free membership includes provider access, program support, and member benefits.
Wegovy® Consultation Program
Starting at $129
Wegovy® is an FDA-approved prescription medication for chronic weight management in adults who meet specific BMI criteria. It contains semaglutide, a GLP-1 receptor agonist that helps regulate appetite and food intake through the brain–gut connection.
Free membership includes provider access, program support, and member benefits.
Who Might Be Eligible for Wegovy®?
You may qualify for Wegovy® if you meet clinical criteria for chronic weight management, which typically include:
- BMI of 30 or higher, or
- BMI of 27 or higher with at least one weight-related health factor, such as insulin resistance, prediabetes, PCOS, high blood pressure, or abnormal cholesterol levels
Eligibility is not based on BMI alone. A licensed BeyondMD provider reviews your medical history, current medications, metabolic health, and weight-related goals to determine whether Wegovy is an appropriate and safe option.
Some individuals with a BMI between 25–26.9 may be considered on a case-by-case basis when additional metabolic risk factors are present.
Final approval is always determined through a provider-led clinical evaluation to ensure responsible, personalized care.
Why Choose Wegovy®?
Wegovy® stands out as a clinically proven option for individuals seeking structured, long-term weight management under medical supervision. Key advantages include:
- FDA-approved for chronic weight management
Specifically indicated for adults with obesity or overweight plus weight-related health factors. - Targets appetite regulation at the hormonal level
As a GLP-1 receptor agonist, Wegovy helps reduce hunger, cravings, and overeating by reinforcing natural satiety signals. - Clinically meaningful results
Studies show average weight loss of 15% or more when used consistently alongside nutrition and lifestyle changes. - Once-weekly convenience
Simple, at-home injections fit easily into real-life routines without frequent clinic visits. - Provider-guided care
Treatment includes personalized dosing, gradual titration, and ongoing clinical oversight to optimize results and manage side effects. - Designed for sustainability
Wegovy supports consistency, adherence, and metabolic alignment—critical factors for maintaining progress beyond short-term weight loss.
Through BeyondMD, Wegovy is delivered as part of a medically guided program focused on safety, personalization, and long-term success.
What’s Included in the Wegovy® Program?
The BeyondMD Wegovy® program delivers structured, clinician-led support designed to simplify treatment and improve long-term outcomes. Your program includes:
- Provider evaluation and prescription (if approved)
A licensed medical provider reviews your health history, goals, and eligibility before prescribing Wegovy. - Personalized dosing and titration plan
Gradual dose escalation tailored to your response, helping optimize results while minimizing side effects. - Ongoing clinical oversight
Continued access to BeyondMD’s care team for guidance, adjustments, and progress monitoring throughout treatment. - Medication coordination and home delivery
Wegovy is shipped discreetly to your door through authorized pharmacy partners, with convenience built in. - Optional insurance support
Complimentary insurance verification available upon request to help clarify coverage and cost expectations. - Long-term weight management focus
Care is structured around sustainability, adherence, and metabolic health—not short-term fixes.
The program is designed to remove friction, provide medical accountability, and support consistent progress from start to finish.
Safety Information
Wegovy® (semaglutide) is an FDA-approved prescription medication for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related medical condition. It is intended for use alongside a reduced-calorie nutrition plan and increased physical activity, under medical supervision.
Important Safety Considerations
- Wegovy should not be used with other GLP-1 medications or products containing semaglutide.
- Do not use Wegovy if you:
- Are pregnant, planning to become pregnant, or breastfeeding
- Have a personal or family history of medullary thyroid carcinoma (MTC)
- Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Are allergic to semaglutide or any of its ingredients
Before starting treatment, inform your provider about all medications and supplements you are taking, including insulin or sulfonylureas, as Wegovy can affect blood sugar levels and medication absorption.
Common Side Effects
Side effects are most common during dose escalation and often improve over time. They may include:
- Nausea, vomiting, or diarrhea
- Constipation or abdominal discomfort
- Indigestion or bloating
- Headache or fatigue
- Dizziness or reflux symptoms
- Low blood sugar, particularly in individuals with type 2 diabetes
Your BeyondMD provider will guide dosing adjustments and offer strategies to improve tolerance.
Medical Oversight
Wegovy is prescribed only after a licensed BeyondMD provider reviews your full health profile to determine clinical appropriateness. Treatment includes ongoing monitoring to support safety, effectiveness, and long-term success.
This information is not exhaustive. Wegovy should be used only as prescribed and in accordance with provider guidance.
Your Treatment Journey
Ready to Take Control of Your Nutrition and Energy?
Discover how once-weekly GLP-1 therapy can simplify appetite management and support steady, sustainable change.
Frequently Asked Questions About Wegovy®
What is Wegovy® and how does it work?
Wegovy® is an FDA-approved GLP-1 medication containing semaglutide. It works by reinforcing natural satiety signals in the brain, helping reduce appetite, curb cravings, and support consistent calorie control when paired with nutrition and lifestyle changes.
Who is eligible for Wegovy®?
Adults with a BMI of 30 or higher, or 27 or higher with a weight-related health factor (such as insulin resistance, prediabetes, PCOS, high blood pressure, or abnormal cholesterol) may qualify. Final eligibility is determined after a provider-led clinical review.
What kind of results can I expect?
Clinical data show average weight loss of 15% or more over time when Wegovy is used consistently alongside dietary and lifestyle adjustments. Results vary, but progress is typically gradual and sustainable.
How is Wegovy® taken?
Wegovy is administered as a once-weekly subcutaneous injection in the abdomen, thigh, or upper arm. Treatment starts at a low dose and increases gradually over several weeks to support tolerance and effectiveness.
What are the most common side effects?
Common side effects may include nausea, constipation, diarrhea, headache, fatigue, or mild digestive discomfort—especially during dose escalation. These often improve as the body adjusts. Providers offer guidance to help manage symptoms.
Can Wegovy® be combined with other weight loss medications?
No. Wegovy should not be used with other GLP-1 medications or products containing semaglutide. Always disclose all medications and supplements to your provider.
Is Wegovy® a short-term solution?
Wegovy is intended for long-term weight management. It supports consistency and adherence, which are critical for maintaining results beyond initial weight loss.
How does BeyondMD support treatment?
BeyondMD provides licensed-provider evaluations, personalized dosing plans, ongoing clinical oversight, and convenient home delivery—designed to support safety, adherence, and long-term success.
